TruNativ secures $30M in Series B funding, led by OrbiMed
TruNativ will use the funds to expand its distribution network across D2C, quick commerce, modern trade, pharmacy, and other retail channels. The funding will also be used for the expansion of its B2B2C ingredient business.










